SILK

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Silk Road Medical Inc

Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke.
CEO
Erica Rogers
Employees
281
Headquarters

1213 Innsbruck Dr
Sunnyvale, California 94089-1317
Phone: 16505669060
silkroadmed.com

News

Silk Road Medical downgraded at Argus on CMS coverage decision
Sep 21, 2023 16:42pm

Argus has downgraded Silk Road Medical to hold after CMS covered a competing product. Read more here.


Source:Seeking Alpha
Medical Device Provider Silk Road Pioneers Innovative Stroke Prevention Method: Analyst
Sep 06, 2023 18:52pm

Oppenheimer has initiated coverage on Silk Road Medical Inc (NASDAQ: SILK ) with an Outperform rating and price target of $30 . Analysts Suraj Kalia and Shaymus Contorno note that Silk Road Medical has been at the forefront of introducing the Transcarotid Artery Revascularization (TCAR) method, an innovative procedure for stroke prevention in patients with carotid stenosis. Since its approval in 2015, SILK''s revenues have grown impressively, with a four-year CAGR of 42%, leading to yearly sales of around $182 … Full story available on Benzinga.com


Source:Benzinga
Citi maintains Silk Road Medical at ''buy'' with a price target of $35.00
Aug 14, 2023 09:04am

https://www.investing.com/news/pro/silk-road-medical-inc-receives-investment-bank-analyst-rating-update-3153246


Source:Investing.com
Silk Road Medical: Unsure On Economics Given List Of Probabilities (Rating Downgrade)
Aug 10, 2023 07:50am

The outlook for Silk Road Medical is mixed, with potential capital budgeting constraints and exogenous risks from the marketplace. See why SILK stock is a Hold.


Source:Seeking Alpha
Silk Road Medical to Present at the UBS MedTech, Tools and Genomics Summit
Aug 03, 2023 20:30pm

SUNNYVALE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming UBS MedTech, Tools and Genomics Summit .


Source:GlobeNewswire
Silk Road Medical GAAP EPS of -$0.35 beats by $0.03, revenue of $45.3M beats by $2.13M
Aug 01, 2023 20:21pm

Silk Road Medical press release (SILK): Q2 GAAP EPS of -$0.35 beats by $0.03.Revenue of $45.3M (+36.6% Y/Y) beats by $2.13M.2023 Financial GuidanceSilk Road Medical projects revenue…


Source:Seeking Alpha
Silk Road Medical Reports Second Quarter 2023 Financial Results
Aug 01, 2023 20:05pm

SUNNYVALE, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2023.


Source:GlobeNewswire